Intracorneal inlay complicated by intrastromal epithelial opacification

被引:42
作者
Alió, JL
Mulet, ME
Zapata, LF
Vidal, MT
De Rojas, V
Javaloy, J
机构
[1] Inst Oftalmol Alicante, Corneal & Refract Surg Dept, Alicante 03016, Spain
[2] Inst Oftalmol Alicante, Cornea Dept, Alicante 03016, Spain
[3] Miguel Hernandez Univ, Div Ophthalmol, Alicante, Spain
[4] Pontificia Bolivariana Univ, Dept Ophthalmol, Medellin, Colombia
[5] Univ Santiago de Compostela, Inst Gallego Oftalmol, Santiago De Compostela, Spain
关键词
D O I
10.1001/archopht.122.10.1441
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To report epithelial perilenticular opacity as a new complication of intracorneal inlay implantation for the correction of hyperopia. Design: Prospective observational case series. Participants: Eleven eyes of 7 patients underwent intracorneal inlay implantation for the correction of hyperopia. Methods: Intracorneal inlays were implanted onto the stromal bed by using a microkeratome cut to create an inferior hinged corneal flap. Main Outcome Measures: Postoperative complication occurrence of intracorneal perilenticular opacity, microbiological laboratory analysis, histopathological analysis, and confocal microscopy study. Results: Of 11 implanted eyes, 5 showed diffuse perilenticular opacity of varying intensity that was unresponsive to steroid use following intracorneal inlay implantation. All patients had moderate to severe loss of best-corrected visual acuity. The inlays showed deposits at the edge and on the surface. Confocal microscopy in all eyes produced images compatible with the confocal morphologic features of epithelial cells. Explantation of inlays was performed in 5 eyes. The histopathologic study showed the presence of epithelial cells, and microbiological analysis and cultures were negative for bacteria, fungi, and mycobacteria. Conclusion: Epithelial perilenticular opacity is a new and serious complication in patients with intracorneal inlay implantation for the correction of hyperopia.
引用
收藏
页码:1441 / 1446
页数:6
相关论文
共 27 条
[1]  
Alio J L, 1993, Ocul Immunol Inflamm, V1, P219, DOI 10.3109/09273949309085021
[2]  
Alió JL, 1999, OPHTHALMOLOGY, V106, P2041
[3]  
Alió JL, 2000, J REFRACT SURG, V16, P523
[4]  
ALIO JL, 2002, J CATARACT REFR SURG, V18, P1
[5]  
Barraquer J I, 1966, Int Ophthalmol Clin, V6, P53, DOI 10.1097/00004397-196606010-00004
[6]  
BEEKHUIS WH, 1987, ARCH OPHTHALMOL-CHIC, V105, P116
[7]  
CLIMENHAGA H, 1988, ARCH OPHTHALMOL-CHIC, V106, P818
[8]  
COTRAN RS, 1999, PATOLOGIA ESTRUCTURA, P208
[9]  
Dohlman CH, 1967, ARCH OPHTHALMOL-CHIC, V177, P52
[10]  
Helena MC, 1997, CORNEA, V16, P300